Implantable ATP Algorithm Optimization via Far-Field Morphology
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-tachycardia pacing (ATP) algorithms for treating cardiac arrhythmias have a low success rate and often require painful ICD shocks, with a significant risk of accelerating the rhythm to ventricular fibrillation or prolonging tachyarrhythmia duration.
Innovation Solution
The development of implantable devices that utilize additional electrodes for monitoring ATP attempts, far-field morphology analyses, and measurement of return intervals to optimize pacing algorithms by estimating timing of entrainment, conduction delay, and tachycardia termination, integrating electrical restitution properties to improve the probability of successful tachycardia termination and reduce the need for ICD shocks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current anti-tachycardia pacing (ATP) algorithms are used to treat cardiac arrhythmias, then the treatment can be delivered, but the success rate is low and often requires painful ICD shocks
Solution Approach 1:
The patent implements feedback mechanisms by monitoring the heart's response to pacing stimuli in real-time and adjusting subsequent pacing parameters based on this feedback. The system measures interval timings between paced beats and intrinsic beats, detects entrainment patterns, and modifies pacing strategy accordingly to improve termination success while avoiding unnecessary shocks.
Solution Approach 2:
The patent employs dynamic pacing strategies where pacing parameters (rate, amplitude, duration) are continuously adjusted during the ATP attempt based on the evolving cardiac rhythm. The system transitions from fixed algorithms to adaptive protocols that respond to real-time electrophysiological changes, optimizing the balance between achieving termination and minimizing harmful effects.
2Reliability
If ATP is delivered to terminate tachycardia, then the arrhythmia can be treated, but the rhythm may be accelerated to ventricular fibrillation or the tachyarrhythmia duration may be prolonged
Solution Approach 1:
The patent applies preliminary actions by delivering conditioning pacing stimuli before the main termination attempt. These preliminary beats are designed to prime the cardiac tissue, create favorable electrophysiological conditions, and reduce the risk of proarrhythmic effects during subsequent higher-energy pacing attempts.
Solution Approach 2:
The system implements cushioning mechanisms by incorporating safety margins and progressive escalation protocols. Rather than immediately delivering high-energy pacing that could trigger fibrillation, the system starts with lower-energy stimuli and gradually increases intensity only when necessary, cushioning against potential harmful acceleration to ventricular fibrillation.
3Reliability
If additional electrodes and monitoring are used to optimize pacing algorithms, then the probability of successful tachycardia termination improves, but the device complexity increases
Solution Approach 1:
The patent achieves multi-functionality by designing electrodes and circuitry that serve multiple purposes: sensing intrinsic beats, delivering pacing stimuli, measuring interval timings, and detecting entrainment patterns. This universal design allows the same hardware components to perform various functions required for optimized ATP without proportionally increasing device complexity.
Solution Approach 2:
The system implements self-service by automatically analyzing its own performance data and adjusting parameters without external intervention. The device monitors its own pacing outcomes, calculates interval timings, detects entrainment patterns, and autonomously optimizes subsequent ATP attempts, eliminating the need for complex external monitoring equipment.
Data Source
AI summary
Apparatus, systems and methods are provided for prevention and/or remediation of cardiac arrhythmias, e.g. optimizing anti-tachycardia pacing (ATP) algorithms. More particularly, implantable devices are provided that measure and treat cardiac arrhythmias. By monitoring the ATP attempt from additional electrodes, far-field morphology analyses, and/or measuring the return interval from a failed ATP attempt; the devices may estimate when entrainment has occurred, the amount of delay within the reentrant tachycardia, and/or tachycardia termination/acceleration. These variables and occurrences can be used to optimize the first and/or subsequent ATP attempts. Furthermore, other exemplary embodiments describe methods to integrate electrical restitution properties into the design of ATP pacing algorithms to facilitate tachycardia termination.